Eli Lilly to Invest $850M in U.S. Operations

Pharmaceutical company Eli Lilly and Company intends to invest $850 million in its manufacturing, laboratories, and other facilities within the United States this year in support of the firm’s “potential for growth” and “longstanding commitment to the U.S. market,” the Indianapolis, IN headquartered company announced March 24.

“Our future at Lilly is bright, as we’re on a path to launch 20 new products in a 10-year time frame,” said David A. Ricks, president and chief executive officer of Lilly, in a statement. “As we have for our entire 140-year history, we continue to see Indiana and the United States as attractive places to research and make the medicines that we sell around the world.”

Driven by demand for its existing products and a “robust pipeline of potential medicines,” the company said the investment will include an $85 million expansion of the firm’s Trulicity device assembly operations, upgrades to other existing sites, and the construction of a new facility.

A particular focus of the investments will center on diabetes-related products, the company said, as it develops new offerings for diabetes patients.

“This manufacturing expansion, along with the introduction of several other new treatments over the last two and a half years, will allow Lilly to continue to be a leader in diabetes care,” said Enrique Conterno, president of Lilly Diabetes and Lilly USA, in a company press release.

At a March 24 ceremony in Indianapolis announcing the investment, the company’s president and chief executive officer, David A. Ricks, said further investments in Lilly’s U.S. operations could occur if the federal government changes its taxation policies.

“The equitable treatment of foreign earnings, a lower U.S. corporate tax rate, and U.S. innovation incentives – similar to the rest of the world – will encourage significant investment in the U.S., creating economic growth and good jobs for Americans,” said Ricks.

Click here for information about the PBS Toronto event, May 16-18, 2017

For more articles, news, and equipment reviews, visit our Equipment Zones